Swiss Life Sciences Stock News

As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...

Sonova Holding AG's ( VTX:SOON ) price-to-earnings (or "P/E") ratio of 23.2x might make it look like a sell right now...

With a median price-to-earnings (or "P/E") ratio of close to 20x in Switzerland, you could be forgiven for feeling...

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") above 20x, you may consider...

Alcon (SWX:ALC) delivered third-quarter earnings that surpassed estimates on non-GAAP EPS, while revenue came in slightly below forecasts. The company reaffirmed its 2025 outlook and pointed to ongoing growth in its Surgical and Vision Care segments. See our latest analysis for Alcon. Alcon’s share price rose sharply in after-hours trading following its upbeat Q3 report but remains down 19.2% for the year to date. While year-to-date momentum has been pressured by sector headwinds and margin...

In recent days, Barclays upgraded Givaudan SA from Equalweight to Overweight, citing an improved structural growth outlook as well as an expanded focus on local and regional customers and high-growth markets, while other major analysts updated their ratings as well. Barclays specifically pointed to multi-year opportunities in natural colors reformulation in North America and highlighted that concerns over a potential sharp slowdown in Fine Fragrance may be exaggerated, supporting the...

Montana Aerospace reported third quarter and nine-month 2025 earnings, posting sales of €250.11 million and €718.79 million respectively, with a net loss for the period despite strong operational growth and the company's transition to a pure-play aerospace business following divestments. While the company showed increased revenue and a reduced net loss year-on-year, its significant downward revision of 2025 financial guidance stood out against positive business transformation and backlog...

Sandoz Group AG recently announced a global license agreement with EirGenix Inc. to commercialize a proposed biosimilar of pertuzumab, a key oncology medicine for HER2-positive breast cancer, granting Sandoz exclusive rights in most global markets with a total consideration of up to US$152 million in milestone payments. This agreement further deepens Sandoz’s existing collaboration with EirGenix, expanding its biosimilar oncology portfolio and enhancing its position to access an estimated...

ams-OSRAM recently unveiled a new generation of advanced laser and lighting technologies, including a 5-junction edge-emitting laser to enhance lidar systems for vehicles and the PLPM7 Vegalas™ laser for high-powered projection and industrial uses. By holding over 30% of the global automotive LED market and pioneering technologies like Mini LED flexible foils, ams-OSRAM continues to play a central role as a preferred supplier to leading automakers and high-end vehicle markets. We'll explore...

Swiss Re reported in November 2025 that its net profit for the first nine months rose by 85% year-on-year to US$4.04 billion, surpassing analyst forecasts, due primarily to lower claims related to natural disasters following a challenging first quarter. This result highlights Swiss Re's exposure to volatility from natural catastrophe events, but also its capacity to benefit when losses are subdued, reflecting the powerful impact of underwriting conditions on reinsurance operations. We'll now...

As European markets face a pullback, with the STOXX Europe 600 Index down 1.24% amid concerns over artificial intelligence stock valuations, investors are increasingly looking for stability in dividend stocks. In this environment, a good dividend stock is often characterized by its ability to offer consistent yields and financial resilience, providing potential income even when broader market sentiment is cautious.

In recent days, U.S. President Donald Trump announced that discussions are ongoing with Switzerland to potentially lower the 39% tariff on Swiss exports to the United States, which had been imposed in August. This prospective easing of trade barriers has brought renewed optimism to Swiss exporters, signaling possible relief for companies affected by the tariffs. We will explore how the prospect of reduced U.S. tariffs may recalibrate Swatch Group’s investment narrative around international...

Investors in Alcon Inc. ( VTX:ALC ) had a good week, as its shares rose 5.9% to close at CHF62.88 following the release...

OC Oerlikon Management AG recently announced that Marco Freidl will take over as Chief Financial Officer and Dr. Andreas Weiss will join the Executive Committee as General Counsel, following the expected divestment of Barmag to Rieter in late 2025. The appointments introduce finance and legal leaders with deep company experience and capital markets backgrounds, reflecting OC Oerlikon's ongoing transformation and increased focus on core surface solutions. We'll examine how the addition of an...

Cosmo Pharmaceuticals (SWX:COPN) has strengthened its sustainability profile following an upgraded ESG rating from S&P Global as well as a Bronze Medal from EcoVadis for its Italian facility. These developments offer investors an updated lens on the company's governance and environmental integration. See our latest analysis for Cosmo Pharmaceuticals. Momentum has been building behind Cosmo Pharmaceuticals lately, with the share price returning 17.5% over the past three months following the...

Earlier this month, Baloise was awarded the top prize at the Swiss Insurance Innovation Award for its ‘AI Concierge’ project, which uses generative AI to analyze third-party contracts in real time and create personalized insurance policies for motor vehicle clients. This recognition underscores Baloise’s industry leadership and highlights the company’s ability to deliver tailored, efficient solutions through ongoing digital innovation efforts. We’ll now explore how Baloise’s achievement in...

Galenica (SWX:GALE) made headlines by issuing a CHF 250 million fixed rate bond with a 7-year maturity at a 1.08% coupon. This strategic move strengthens long-term financing and repays earlier acquisition-related bridge debt. See our latest analysis for Galenica. The recent bond issuance fits into a year that has seen Galenica focus on stability and longer-term growth, with refinancing efforts building confidence. While the past month’s share price return was a modest negative 2.65%, momentum...

ams-OSRAM (SWX:AMS) has rolled out new high-performance laser and LED technologies, including a 5-junction edge-emitting laser for lidar and the PLPM7 Vegalas laser for projection. These advancements bolster its leadership in automotive lighting. See our latest analysis for ams-OSRAM. ams-OSRAM’s recent rollout of advanced laser and LED technologies came at a time when momentum in its stock price has been noticeable. After a standout year-to-date share price return of 66.8%, the past month...

It's been a mediocre week for LEM Holding SA ( VTX:LEHN ) shareholders, with the stock dropping 18% to CHF357 in the...

Ever wondered if Alcon is a hidden gem that is flying under the radar, or if its stock price already reflects all the upside? You are not alone, and this article aims to clear things up. Alcon’s shares have gained 7.1% over the past week and 9.3% in the past month. However, they are still down 16.1% year-to-date and 16.8% over the last year. Recent news has highlighted renewed interest in the broader healthcare sector as investors look for stability amidst global market...

Clariant AG recently confirmed its earnings guidance for 2025, forecasting local currency sales growth at the lower end of its previously outlined 1% to 3% range. This guidance update signals a degree of caution regarding near-term market conditions and could influence how investors view the company's immediate growth prospects. We’ll look at how Clariant’s updated sales outlook may affect confidence in its margin-focused investment narrative. The end of cancer? These 29 emerging AI stocks...

UBS Group AG recently completed an upsized multi-billion dollar debt tender offer, increasing its maximum purchase consideration from US$4 billion to US$8.6 billion and accepting US$7.67 billion in principal across several note series for buyback. This large-scale reduction of outstanding debt is an important move aimed at optimizing UBS's capital structure and potentially lowering future interest expenses. We'll explore how UBS Group’s sizeable debt buyback could influence its investment...

Key Insights Significant control over OC Oerlikon by private companies implies that the general public has more power...

On November 5, 2025, Swisscom AG released earnings results for the nine months ended September 30, 2025, reporting sales of CHF 11.18 billion, up from CHF 8.16 billion the previous year. While revenue grew significantly, Swisscom's net income and basic earnings per share both declined from the prior period, reflecting mixed operational trends. With earnings showing increased top-line growth but lower profitability, we explore how these results impact Swisscom's broader investment...